FDA Gives Pfizer COVID-19 Vaccine Full Approval

WASHINGTON (AP/KDKA) — The U.S. gave full approval to Pfizer's COVID-19 vaccine on Monday, a milestone that may help lift public confidence in the shots as the nation battles the most contagious coronavirus mutant yet.

The vaccine made by Pfizer and its partner BioNTech now carries the strongest endorsement from the Food and Drug Administration, which has never before had so much evidence to judge a shot's safety. More than 200 million Pfizer doses already have been administered in the U.S. — and hundreds of millions more worldwide — since emergency use began in December.

"The public can be very confident that this vaccine meets the high standards for safety, effectiveness and manufacturing quality the FDA requires of an approved product," said acting FDA Commissioner Janet Woodcock. "Today's milestone puts us one step closer to altering the course of this pandemic in the U.S."

Gov. Tom Wolf said on Twitter that he hopes the full approval will prompt people on the fence about vaccination to talk to their health care providers.

"It's the best way to protect yourself and your community," Wolf said.

The vaccine is approved for people 16 and older and continues to be available under emergency use authorization for ages 12-15 and as a third shot for those with weakened immune systems.

The U.S. becomes the first country to fully approve the shot, according to Pfizer, and CEO Albert Bourla said in a statement he hoped the decision "will help increase confidence in our vaccine, as vaccination remains the best tool we have to help protect lives."

In Pennsylvania, nearly 12 million shots have gone into arms and over 5.8 million people are fully vaccinated.

(Copyright 2020 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)

In:
• COVID-19 Vaccine
• Coronavirus
• Pfizer